FeesSafety
Pluang+

Slop Cash (SLOP) public auction opens on Robinhood Chain after $400K minimum met

Protocol Fundamentals
09 Nov 2026, 10:45 WIB
Tokenpost
View Source
Bullish
Slop Cash (SLOP) public auction opens on Robinhood Chain after $400K minimum met

Slop Cash (SLOP) token auction entered its public phase on Nov. 7 after early bids met the $400,000 minimum on Robinhood Chain. Over 200 bidders participated across three access lanes, with the community lane fully subscribed on day one. The auction offers 45 million SLOP tokens, funding open-source software projects and giving holders a say in treasury decisions. Bidding closes on Nov. 10.

Slop Cash token auction is underway, with over 200 bidders and a $400,000 minimum met. For readers following major cryptocurrencies, here is Pluang's market snapshot as of Nov 09, 2026 16:01 WIB: out of 50 major cryptos, 6 rose and 43 fell. Balancer (BAL) rose 11.14% to Rp16.297, EOS (EOS.IO) gained 8.13% to Rp12.649, while Ripple (XRP) dropped 5.56% to Rp19.874 with 62% buy orders.

More News

Oculis to host R&D Day showcasing late-stage pipeline for dry eye and neuro-ophthalmology treatments

Oculis to host R&D Day showcasing late-stage pipeline for dry eye and neuro-ophthalmology treatments

Oculis Holding AG announced an in-person and virtual R&D Day on December 8, 2026, to highlight key clinical developments in its late-stage pipeline, including Licaminlimab for dry eye disease and Privosegtor for neuro-ophthalmology and neurology. The...

Market News
Bullish
2 hours ago
DNO ASA's offer for Capricorn Energy plc lapses, ending the acquisition attempt.

DNO ASA's offer for Capricorn Energy plc lapses, ending the acquisition attempt.

DNO ASA announced that its offer to acquire Capricorn Energy plc has lapsed as of November 9, 2026. This means the acquisition attempt will not proceed, impacting DNO's expansion plans in the oil and gas sector. Investors should monitor DNO's next st...

Market News
Neutral
2 hours ago
Oculis announces R&D Day to showcase late-stage eye disease drug developments Licaminlimab and Privosegtor.

Oculis announces R&D Day to showcase late-stage eye disease drug developments Licaminlimab and Privosegtor.

Oculis Holding AG will hold a Research & Development Day on December 8, 2026, to present key clinical progress on its late-stage drug candidates Licaminlimab for dry eye disease and Privosegtor for neuro-ophthalmic conditions including optic neuritis...

Company Fundamentals
Bullish
2 hours ago
Fraudulent robocall losses in North America to drop 33% by 2031 due to advanced fraud prevention.

Fraudulent robocall losses in North America to drop 33% by 2031 due to advanced fraud prevention.

Juniper Research forecasts that losses from fraudulent robocalls in North America will decrease by 33%, from $18.4 billion in 2026 to $12.3 billion in 2031. This decline is attributed to telecom operators adopting advanced fraud prevention technologi...

Market News
Bullish
2 hours ago
Strategy's stock drops 21.6% amid Bitcoin buy funded by share sales and preferred share repurchase.

Strategy's stock drops 21.6% amid Bitcoin buy funded by share sales and preferred share repurchase.

Strategy's common stock fell 21.6% from Oct. 6 to Nov. 6, coinciding with its Bitcoin buying program funded by selling 1.18 million shares, raising $164 million. The company spent $65.5 million to acquire 811 BTC at an average price of $80,846 each, ...

Market News
Bearish
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App